Compare ZCMD & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZCMD | COCH |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Blank Checks |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 24.4M |
| IPO Year | 2020 | N/A |
| Metric | ZCMD | COCH |
|---|---|---|
| Price | $0.57 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 14.9K | ★ 434.7K |
| Earning Date | 12-24-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,117,523.00 | $208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.48 | $0.64 |
| 52 Week High | $2.28 | $2.00 |
| Indicator | ZCMD | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 39.97 |
| Support Level | $0.58 | $0.80 |
| Resistance Level | $0.63 | $0.77 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 66.94 | 25.13 |
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.